Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some may still have unproven business models, leaving them vulnerable to the ebbs and flows of the broader market.

Luckily for you, our mission at StockStory is to help you make money and avoid losses by sorting the winners from the losers. That said, here are three stocks under $50 to avoid and some other investments you should consider instead.

DoubleVerify (DV)

Share Price: $9.07

Using advanced analytics to evaluate over 17 billion digital ad transactions daily, DoubleVerify (NYSE: DV) provides AI-powered technology that verifies digital ads are viewable, fraud-free, brand-suitable, and displayed in the intended geographic location.

Why Do We Think DV Will Underperform?

1. 13.7% annual revenue growth over the last two years was slower than its software peers
2. Customer acquisition costs take a while to recoup, making it difficult to justify sales and marketing investments that could increase revenue
3. Operating margin didn’t move over the last year, showing it couldn’t increase its efficiency

DoubleVerify’s stock price of $9.07 implies a valuation ratio of 5.1x forward price-to-sales. If you’re considering DV for your portfolio, see our FREE research report to learn more.

Sotera Health Company (SHC)

Share Price: $15.27

With a critical role in ensuring the safety of millions of patients worldwide, Sotera Health (NASDAQGS:SHC) provides sterilization services, lab testing, and advisory services to ensure medical devices, pharmaceuticals, and food products are safe for use.

Why Is SHC Not Exciting?

1. Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth
2. Smaller revenue base of $1.19 billion means it hasn’t achieved the economies of scale that some industry juggernauts enjoy
3. 8.4 percentage point decline in its free cash flow margin over the last five years reflects the company’s increased investments to defend its market position

At $15.27 per share, Sotera Health Company trades at 15.5x forward P/E. Check out our free in-depth research report to learn more about why SHC doesn’t pass our bar.

PROG (PRG)

Share Price: $33.24

Evolving from its origins as Aaron's, Inc. before rebranding in 2020, PROG Holdings (NYSE: PRG) provides alternative payment solutions including lease-to-own options and second-look credit products for consumers who may not qualify for traditional financing.

Why Should You Dump PRG?

1. Flat sales over the last five years suggest it must find different ways to grow during this cycle
2. Sales over the last five years were less profitable as its earnings per share fell by 5.4% annually while its revenue was flat
3. Products and services are facing significant credit quality challenges during this cycle as tangible book value per share has declined by 62.4% annually over the last five years

PROG is trading at $33.24 per share, or 7.7x forward P/E. To fully understand why you should be careful with PRG, check out our full research report (it’s free).

High-Quality Stocks for All Market Conditions

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum - both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks - FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.